NCT06936527 2025-09-03
XS-03-II201
NovaOnco Therapeutics Co., Ltd.
Phase 1/2 Enrolling by invitation
Clinical Trials
10 trialsNCT03526835 2025-01-29
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Merus B.V.
Phase 1/2 Recruiting
NCT06509880 2024-07-19
ISMCC
MIPO Clinic
Phase 1/2 Active not recruiting
NCT03202758 2023-02-10
MEDITREME
Centre Georges Francois Leclerc
Phase 1/2 Completed
NCT05721872 2023-02-10
Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer
Nazarbayev University
Phase 1/2 Unknown
NCT03254394 2022-03-09
Lidocaine for Oxaliplatin-induced Neuropathy
Washington University School of Medicine
Phase 1/2 Completed
NCT01490996 2020-01-31
CUFOX
University of Leicester
Phase 1/2 Completed
NCT00778830 2015-05-14
APEC
Merck KGaA, Darmstadt, Germany
Phase 1/2 Completed
NCT00494221 2014-03-27
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
AstraZeneca
Phase 1/2 Completed
NCT00478946 2009-01-21
A Study of Picoplatin in Colorectal Cancer
Poniard Pharmaceuticals
Phase 1/2 Unknown